| pubmed-article:15159414 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15159414 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:15159414 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:15159414 | lifeskim:mentions | umls-concept:C0024301 | lld:lifeskim |
| pubmed-article:15159414 | lifeskim:mentions | umls-concept:C0393022 | lld:lifeskim |
| pubmed-article:15159414 | lifeskim:mentions | umls-concept:C0026259 | lld:lifeskim |
| pubmed-article:15159414 | lifeskim:mentions | umls-concept:C0059985 | lld:lifeskim |
| pubmed-article:15159414 | lifeskim:mentions | umls-concept:C1413947 | lld:lifeskim |
| pubmed-article:15159414 | lifeskim:mentions | umls-concept:C0055598 | lld:lifeskim |
| pubmed-article:15159414 | pubmed:issue | 13 | lld:pubmed |
| pubmed-article:15159414 | pubmed:dateCreated | 2004-6-30 | lld:pubmed |
| pubmed-article:15159414 | pubmed:abstractText | Promising new therapeutic options for follicular lymphoma (FL) include fludarabine plus mitoxantrone (FM) and the mouse/human anti-CD20 antibody, rituximab. We performed a randomized comparative trial of FM with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) front-line chemotherapy with and without sequential rituximab. | lld:pubmed |
| pubmed-article:15159414 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15159414 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15159414 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15159414 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15159414 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15159414 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15159414 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15159414 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15159414 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15159414 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15159414 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15159414 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15159414 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:15159414 | pubmed:issn | 0732-183X | lld:pubmed |
| pubmed-article:15159414 | pubmed:author | pubmed-author:FaliniBrunang... | lld:pubmed |
| pubmed-article:15159414 | pubmed:author | pubmed-author:BaccaraniMich... | lld:pubmed |
| pubmed-article:15159414 | pubmed:author | pubmed-author:TuraSanteS | lld:pubmed |
| pubmed-article:15159414 | pubmed:author | pubmed-author:De... | lld:pubmed |
| pubmed-article:15159414 | pubmed:author | pubmed-author:PulsoniAlessa... | lld:pubmed |
| pubmed-article:15159414 | pubmed:author | pubmed-author:ZajaFrancesco... | lld:pubmed |
| pubmed-article:15159414 | pubmed:author | pubmed-author:ZinzaniPier... | lld:pubmed |
| pubmed-article:15159414 | pubmed:author | pubmed-author:GobbiMarcoM | lld:pubmed |
| pubmed-article:15159414 | pubmed:author | pubmed-author:PileriStefano... | lld:pubmed |
| pubmed-article:15159414 | pubmed:author | pubmed-author:FattoriPier... | lld:pubmed |
| pubmed-article:15159414 | pubmed:author | pubmed-author:SoveriniSimon... | lld:pubmed |
| pubmed-article:15159414 | pubmed:author | pubmed-author:MolinariAnna... | lld:pubmed |
| pubmed-article:15159414 | pubmed:author | pubmed-author:AlinariLapoL | lld:pubmed |
| pubmed-article:15159414 | pubmed:author | pubmed-author:MartelliMauri... | lld:pubmed |
| pubmed-article:15159414 | pubmed:author | pubmed-author:PerrottiAless... | lld:pubmed |
| pubmed-article:15159414 | pubmed:author | pubmed-author:GentiliniPatr... | lld:pubmed |
| pubmed-article:15159414 | pubmed:author | pubmed-author:StortiSergioS | lld:pubmed |
| pubmed-article:15159414 | pubmed:author | pubmed-author:LautaVito... | lld:pubmed |
| pubmed-article:15159414 | pubmed:author | pubmed-author:GuardigniLuci... | lld:pubmed |
| pubmed-article:15159414 | pubmed:author | pubmed-author:TucciAlessand... | lld:pubmed |
| pubmed-article:15159414 | pubmed:author | pubmed-author:CicconeFabriz... | lld:pubmed |
| pubmed-article:15159414 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15159414 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:15159414 | pubmed:volume | 22 | lld:pubmed |
| pubmed-article:15159414 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15159414 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15159414 | pubmed:pagination | 2654-61 | lld:pubmed |
| pubmed-article:15159414 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:15159414 | pubmed:meshHeading | pubmed-meshheading:15159414... | lld:pubmed |
| pubmed-article:15159414 | pubmed:meshHeading | pubmed-meshheading:15159414... | lld:pubmed |
| pubmed-article:15159414 | pubmed:meshHeading | pubmed-meshheading:15159414... | lld:pubmed |
| pubmed-article:15159414 | pubmed:meshHeading | pubmed-meshheading:15159414... | lld:pubmed |
| pubmed-article:15159414 | pubmed:meshHeading | pubmed-meshheading:15159414... | lld:pubmed |
| pubmed-article:15159414 | pubmed:meshHeading | pubmed-meshheading:15159414... | lld:pubmed |
| pubmed-article:15159414 | pubmed:meshHeading | pubmed-meshheading:15159414... | lld:pubmed |
| pubmed-article:15159414 | pubmed:meshHeading | pubmed-meshheading:15159414... | lld:pubmed |
| pubmed-article:15159414 | pubmed:meshHeading | pubmed-meshheading:15159414... | lld:pubmed |
| pubmed-article:15159414 | pubmed:meshHeading | pubmed-meshheading:15159414... | lld:pubmed |
| pubmed-article:15159414 | pubmed:meshHeading | pubmed-meshheading:15159414... | lld:pubmed |
| pubmed-article:15159414 | pubmed:meshHeading | pubmed-meshheading:15159414... | lld:pubmed |
| pubmed-article:15159414 | pubmed:meshHeading | pubmed-meshheading:15159414... | lld:pubmed |
| pubmed-article:15159414 | pubmed:meshHeading | pubmed-meshheading:15159414... | lld:pubmed |
| pubmed-article:15159414 | pubmed:meshHeading | pubmed-meshheading:15159414... | lld:pubmed |
| pubmed-article:15159414 | pubmed:meshHeading | pubmed-meshheading:15159414... | lld:pubmed |
| pubmed-article:15159414 | pubmed:meshHeading | pubmed-meshheading:15159414... | lld:pubmed |
| pubmed-article:15159414 | pubmed:meshHeading | pubmed-meshheading:15159414... | lld:pubmed |
| pubmed-article:15159414 | pubmed:meshHeading | pubmed-meshheading:15159414... | lld:pubmed |
| pubmed-article:15159414 | pubmed:meshHeading | pubmed-meshheading:15159414... | lld:pubmed |
| pubmed-article:15159414 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15159414 | pubmed:articleTitle | Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma. | lld:pubmed |
| pubmed-article:15159414 | pubmed:affiliation | Institute of Hematology and Medical Oncology L. e A. Seràgnoli, University of Bologna, Italy. plzinzo@med.unibo.it | lld:pubmed |
| pubmed-article:15159414 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15159414 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15159414 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:15159414 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:15159414 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15159414 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15159414 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15159414 | lld:pubmed |
